Gilead Sciences, Inc. (BIT:1GILD)
Italy · Delayed Price · Currency is EUR 105.12
-0.64 (-0.61%)
At close: Dec 30, 2025
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of €129.7 billion as of January 2, 2026. Its market cap has increased by 18.92% in one year.
Market Cap
129.70B
Enterprise Value
141.93B
Revenue
24.79B
Ranking
n/a
PE Ratio
18.76
Stock Price
€105.12
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 194.48M to 129.70B, an increase of 66,589.91%. That is a compound annual growth rate of 21.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 129.70B | 16.64% |
| Dec 31, 2024 | 111.19B | 21.76% |
| Dec 29, 2023 | 91.32B | -9.36% |
| Dec 30, 2022 | 100.75B | 25.80% |
| Dec 31, 2021 | 80.09B | 34.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 9.93B |
| DiaSorin | 3.70B |
| Amplifon | 3.02B |
| EL.En. | 1.11B |
| Philogen | 938.16M |
| Safilo Group | 797.82M |
| Pharmanutra | 521.46M |
| Garofalo Health Care | 493.78M |